Abstract:Introduction Speaking prospectively we use the concept of "at risk mental state" (ARMS) to describe the state in which a person has a heightened risk of developing a psychotic disorder. Young people who are experiencing ARMS can be more precisely defined as being at ultra-high-risk of psychosis using a specific set of criteria known as the UHR criteria. Objectives To clarify the concept of ultra-high-risk individuals and to characterize the clinical and functional characteristics and general psychopathology of those individuals that do not transition to psychosis during the follow-up period. Methods Research on UpToDate using the terms "Ultra-High-Risk"; "psychosis", "transition". Results Recent literature has suggested that less than 30% of those who meet established criteria for being at Clinical-High-Risk of psychosis (CHR-P) go on to develop a psychotic illness. It is therefore of crucial importance and relevance to assess and clarify what happens to high-risk individuals who do not transition to psychosis, who make up the vast majority. One of the most recent studies (NAPLS-2) that encompassed 764 of CHR-P individuals who were followed for 2 years, concluded that 278 did not transition to psychosis during the follow-up period. Three clinical outcomes were recorded: 1 group had experienced a psychopathological remission (39.57%); the other kept symptomatic but not currently meeting criteria for a prodromal risk syndrome (33.45%); the third group had a prodromal progression (26.98%). The study concluded among others that although the remission group had improved social functioning at 2 years compared with the other groups, they were still functioning below the healthy control group. Another meta-analysis that included a total of 2756 CHR-P individuals with a mean duration of follow-up of 30.7 months evaluated several clinical outcomes in CHR-P that didn't transitioned to psychosis and between CHR-P non-transitioning versus those transitioning to psychosis. It concluded that CHR-P that do not transition to psychosis have an overall improvement of symptoms (APS, negative, depressive) and functioning at follow-up compared to baseline. Conclusions The occurrence of a first psychotic episode is often devastating for the patient and their family, especially given its usual onset in adolescence and early adulthood. This is a critical period in the individual's development as a person, and disorders at this stage can threaten the potential for a productive and inclusive adult life. Studies have suggested that less than 30% of individuals classified as UHR actually develop a psychotic disorder. However, little is known about the individuals belonging to this group who do not transition to psychosis. We therefore consider it is relevant to clarify the clinical and functional outcomes of this group of individuals. Disclosure of Interest None Declared

Adolescents at Ultra-High Risk for Psychosis: Long-Term Outcome of Individuals Who Recover from Their At-Risk State.

Non-psychotic Outcomes in Young People at Ultra-High Risk of Developing a Psychotic Disorder: A Long-Term Follow-up Study

Neurocognitive and Clinical Predictors of Long-Term Outcome in Adolescents at Ultra-High Risk for Psychosis: a 6-Year Follow-Up.

Ultra-High-Risk that do not transition to psychosis. What happens?

Brain development in adolescents at ultra-high risk for psychosis: Longitudinal changes related to resilience.

Individual Prediction of Long-Term Outcome in Adolescents at Ultra-High Risk for Psychosis: Applying Machine Learning Techniques to Brain Imaging Data

Genetic liability in individuals at ultra-high risk of psychosis: A comparison study of 9 psychiatric traits

Development and temporal validation of a clinical prediction model of transition to psychosis in individuals at ultra‐high risk in the UHR 1000+ cohort

Progressive Structural Brain Changes During Development of Psychosis.

Adverse outcome analysis in people at clinical high risk for psychosis: results from a 2-year Italian follow-up study

Early and later remission from clinical high risk of psychosis. A latent class and predictor analysis

Long-Term Course of Remission and Recovery in Psychotic Disorders

Antipsychotic Treatment Effects on Progression of Brain Pathomorphology in First Episode Schizophrenia

Subtypes of Clinical High Risk for Psychosis That Predict Antipsychotic Effectiveness in Long-Term Remission

Social Cognition in Individuals at Ultra-High Risk for Psychosis: A Meta-Analysis

The relationship between community-based psychiatric rehabilitation pathways and re-hospitalization trajectories: A three-decade follow-up

NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders—medium-term follow-up and clinical course

Long-term remission rates and trajectory predictors in obsessive-compulsive disorder: Findings from a six-year naturalistic longitudinal cohort study

Long-term clinical recovery and treatment resistance in first-episode psychosis: a 10-year follow-up study

Case report: From anxiety disorders to psychosis, a continuum in transitional age youth?

Attachment styles and associated psychosocial factors in patients at ultra-high risk for psychosis: A systematic review